about
Positron emission tomography imaging of prostate cancerAdvance of molecular imaging technology and targeted imaging agent in imaging and therapyPET probes beyond (18)F-FDGMultimodality imaging in vivo for preclinical assessment of tumor-targeted doxorubicin nanoparticles.Positron emission tomography imaging of CD105 expression with a 64Cu-labeled monoclonal antibody: NOTA is superior to DOTAAntibody-based imaging of HER-2: moving into the clinic.Photoacoustic imaging.Nanoparticles for Improving Cancer Diagnosis.Nanobody: the "magic bullet" for molecular imaging?Preclinical lymphatic imaging.Molecular Imaging with Single-Walled Carbon Nanotubes.Anatomical and molecular imaging of skin cancerIn vivo imaging of RNA interference.Targeting the EGF receptor for ovarian cancer therapy.In vivo imaging of molecular targets and their function in endocrinology.Epidermal growth factor receptor in glioma: signal transduction, neuropathology, imaging, and radioresistanceMetabolic stability of 6,7-dialkoxy-4-(2-, 3- and 4-[18F]fluoroanilino)quinazolines, potential EGFR imaging probes.Optimizing tumor targeting of the lipophilic EGFR-binding radiotracer SKI 243 using a liposomal nanoparticle delivery system.PET imaging of EGF receptors using [18F]FBEM-EGF in a head and neck squamous cell carcinoma model.Immuno-PET Imaging of HER3 in a Model in which HER3 Signaling Plays a Critical RoleMolecular imaging of insulin-like growth factor 1 receptor in cancer.Multimodality imaging of breast cancer experimental lung metastasis with bioluminescence and a monoclonal antibody dual-labeled with 89Zr and IRDye 800CW.Labeling and Biological Evaluation of (99m)Tc-HYNIC-Trastuzumab as a Potential Radiopharmaceutical for In Vivo Evaluation of HER2 Expression in Breast Cancer.Molecular imaging of Bcr-Abl phosphokinase in a xenograft model.Radionuclide-Based Cancer Imaging Targeting the Carcinoembryonic Antigen.Targeted Cancer Therapy with Tumor Necrosis Factor-Alpha.Interrogating tumor metabolism and tumor microenvironments using molecular positron emission tomography imaging. Theranostic approaches to improve therapeutics.Imaging of EGFR and EGFR tyrosine kinase overexpression in tumors by nuclear medicine modalities.Quantum dot-based nanoprobes for in vivo targeted imaging.Mapping Sentinel Lymph Node Metastasis by Dual-probe Optical Imaging.Imaging with Raman spectroscopy.Imaging of Induced Pluripotent Stem Cells: From Cellular Reprogramming to Transplantation.Molecular imaging with SERS-active nanoparticles.PET tracers based on Zirconium-89.Specific biomarkers of receptors, pathways of inhibition and targeted therapies: pre-clinical developments.Multimodality imaging of RNA interferenceMolecular imaging using PET for breast cancer.Radiolabelled nanoparticles: novel classification of radiopharmaceuticals for molecular imaging of cancer.A comparative study of affibody, panitumumab, and EGF for near-infrared fluorescence imaging of EGFR- and EGFRvIII-expressing tumors.Evaluation of modified PEG-anilinoquinazoline derivatives as potential agents for EGFR imaging in cancer by small animal PET.
P2860
Q24596241-F6921382-3883-4F07-9DCE-94E2F1088C9CQ26851887-006E2022-84F0-4955-A0F0-9ED13BF17446Q27004457-D16863B6-FB85-48EE-8626-654A4ED977E5Q28482099-6D7E240A-F1E0-48A3-92BC-DCFD3DDF1003Q28741667-9A443AB2-F78E-4363-A497-EEE3CFB3858FQ30423880-299EDB58-A0AE-4F97-9F22-434811C6C3E6Q30430595-1044B0AB-E4D8-47DC-9913-48BB3BED30C6Q30442412-A7C84508-AE2B-451B-9434-A7F31278E5B1Q30442626-050C695F-0CB8-4A53-8C2B-02522417792BQ30465292-0E0AFD9C-5C61-4B46-8A19-DAC0C8DE4CCAQ30474862-10B879FD-036E-438D-BD15-CE34D0B586A5Q30476227-C3FBABA8-09CD-4707-AB69-7BFF6182F3F2Q33348480-7A598AD5-16EF-4EEE-9795-F8C8F14E5EF7Q33570526-789CD6C9-17F3-4969-A5DA-4211B3B24ACFQ33637199-CCB851B8-DD6C-4AE7-8EC7-6A202B303750Q34105339-0BBC0BEB-F138-45E4-A547-071E975E3362Q34996212-1F4B349A-51DA-4C8A-AD9E-1C267CEA260FQ35676118-FD8605DC-1170-4A47-A595-23A8FEF3D297Q35683116-81D4F0AB-CE22-452D-86BA-30731E8D50DDQ35842236-AAC49A66-6931-4F3A-A240-CCE399BFD6D2Q36337268-8C922702-BF41-4459-BDB4-9988645CD34AQ36406701-89D5A28B-46DF-4795-ABAE-3D1A6A3CD1A2Q37100372-66B92B22-B810-4CAC-BFB7-11B7977123A3Q37185378-0783BAB2-03B6-4468-A1CD-D4A70A761204Q37207310-2643B54A-8880-476B-8BC9-BF1951A9B145Q37220415-ED285ABB-2285-4A3F-9E27-0F5224A4FAACQ37236103-AAC1DF8D-5D46-4634-A265-391AD3DFC222Q37320501-67E2E02B-B03C-444D-B941-FE585DA5DD08Q37337213-4B4EC2ED-A1C0-4EB2-9253-EC239E502DB0Q37541860-50ADB4F3-D783-43CA-A429-0937F1B36B2DQ37760230-943E430C-8AEE-4933-AA4B-06057B6C6703Q37917591-DEC04F57-96B6-4ACA-B97C-9A9B35BD892FQ37935679-783A392C-8B87-471D-9832-648BC677A583Q37970745-1C38897F-4E25-4225-8C10-1BDFA74E6587Q37995451-EBAF7890-9B3F-4A81-8B39-C86C6055BF39Q38112726-03C03E47-558D-4B40-8613-73DE71A19AA2Q38444869-68126498-FDD9-46E9-A4CE-2D111AB1C76BQ38997208-7674413A-C833-460B-BBB4-B067FA82D575Q39084992-92BE466A-A725-4413-A53A-48F3FF2A28DCQ39716869-CB10D0C7-0B93-418B-A406-BD8633CF50CE
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Multimodality imaging of the HER-kinase axis in cancer.
@en
type
label
Multimodality imaging of the HER-kinase axis in cancer.
@en
prefLabel
Multimodality imaging of the HER-kinase axis in cancer.
@en
P2860
P1476
Multimodality imaging of the HER-kinase axis in cancer.
@en
P2093
P2860
P2888
P304
P356
10.1007/S00259-007-0560-9
P577
2007-09-11T00:00:00Z